-
Mashup Score: 1Stroke Detection Innovator Wellumio Expands into the U.S. Market - 2 month(s) ago
/PRNewswire/ — Wellumio, a New Zealand-based medical device company pioneering advancements in stroke detection, is expanding its global footprint by…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities - 2 month(s) ago
/PRNewswire/ — ScreenPoint Medical today announced the acquisition of Biomediq A/S, a research-based company focused on the research, development and…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet-
.@screenpointmed Acquires Biomediq A/S to Expand #BreastCancer Risk Assessment Capabilities | #MnA #radiology #AI https://t.co/OT4Lj82YKT
-
-
Mashup Score: 0Children's Hospital of Philadelphia Researchers Develop New Tool with Potential to Advance Precision Medicine Treatment for Cancer - 2 month(s) ago
/PRNewswire/ — Researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania developed a new…
Source: www.prnewswire.comCategories: General Medicine News, PediatricsTweet-
"Researchers at @ChildrensPhila & @PennMedicine developed a new screening technology to better identify antigen-reactive T cells that are more likely to offer greater immune responses against cancer cells." Learn more: https://t.co/qhLfDMep2X
-
-
Mashup Score: 65
/PRNewswire/ — GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating…
Source: www.prnewswire.comCategories: General Medicine News, Hem/OncsTweet-
GORTEC announces that the NIVOPOSTOP study (NCT03576417) met its primary endpoint of Disease-Free survival (DFS) across all comers high risk resected HNSCC. Combined with KN689 this represents the 2nd positive IO trial in the postop setting. https://t.co/tuRnnvf5Pc https://t.co/CrsKKBFU7W
-
-
Mashup Score: 0
/PRNewswire/ — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet-
.@HealthCatalyst Launches #AI-Enabled Cyber Protection Product for #Healthcare | #cybersecurity https://t.co/YBzuyJy9Xe
-
-
Mashup Score: 8MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH - 3 month(s) ago
DA-1241 Demonstrated Direct Hepatic Action in Addition to Its Glucose Lowering Effect Patients Treated with DA-1241 100mg Achieved Statistically Significant…
Source: www.prnewswire.comCategories: General Medicine News, Expert PicksTweet-
MetaVia announces positive Phase 2a results of DA-1241, a novel G-Protein-Coupled Receptor 119 (#GPR119) agonist compared to placebo in #MASH. 100mg significantly reduced ALT levels at weeks 4 and 8 and yielded similar trends in other liver enzymes. https://t.co/TINzZ8nCwx
-
-
Mashup Score: 2Ryght AI Launches Global Clinical Trial Site Network with the University of Southern California as their First Academic Site. - 3 month(s) ago
/PRNewswire/ — Ryght, a real-time generative AI healthcare technology provider for the clinical research industry, announced today the launch of “The Ryght…
Source: www.prnewswire.comCategories: General Medicine News, Partners & KOLsTweet-
Excited to welcome USC into our growing @RyghtAI global research network. Applying generative #AI into clinical research operations across the spectrum is much needed to accelerate processes and help patients get access to newer therapies faster. https://t.co/i0L4xD2A2g
-
-
Mashup Score: 1
/PRNewswire/ — The National Resident Matching Program® (NRMP®) proudly announces that more than 8,000 resident physicians have successfully secured fellowship…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet-
2024 Match results are in - Rheumatology- 287 matched, 99%: Top 6: 1. Cardi 99.8% 2. Cardio EP 98% 3. Endocrinology 98.4 % 4. GI 99.6% 5. Heme/Onc 99.7% 6. Rheum 99% https://t.co/UYnXc13VvQ https://t.co/kAZ4GACXkL
-
-
Mashup Score: 2
/PRNewswire/ — The National Resident Matching Program® (NRMP®) proudly announces that more than 8,000 resident physicians have successfully secured fellowship…
Source: www.prnewswire.comCategories: General Medicine News, General HCPsTweet-
2024 Match results are in - Rheumatology- 287 matched, 99%: Top 6: 1. Cardi 99.8% 2. Cardio EP 98% 3. Endocrinology 98.4 % 4. GI 99.6% 5. Heme/Onc 99.7% 6. Rheum 99% https://t.co/PBuQPIQaqo https://t.co/xcGbLiEdSw
-
-
Mashup Score: 0
/PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced…
Source: www.prnewswire.comCategories: General Medicine News, Rare DiseaseTweet-
$BCLI https://t.co/V2UUSqvrcf
-
#Stroke Detection Innovator @wellumio Expands into the U.S. Market: Revolutionary #portable #MRI device leverages advanced MR tech to rapidly detect acute stroke biomarkers https://t.co/nbu9XKm3Z1